date:Nov 06, 2015
ber States and professional stakeholder organisations are strongly recommended to report to EFSA their findings on ergot alkaloids by 30 September 2016. Those findings shall include occurrence data and specific information on the relationship between the presence of ergot sclerotia and the level of individual ergot alkaloids.
γγThe Commission shall make those findings available to the Member States.
γγ5. Occurrence data on other contaminants than those referred to in paragraphs 1 to 4 collec